{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:35:08Z","timestamp":1793392508548,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2019B030316001"],"award-info":[{"award-number":["2019B030316001"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011366"],"award-info":[{"award-number":["2019A1515011366"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515011567"],"award-info":[{"award-number":["2022A1515011567"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaacap.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaac.2023.05.031","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T01:13:45Z","timestamp":1688433225000},"page":"507-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-9394","authenticated-orcid":false,"given":"Yanling","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-084X","authenticated-orcid":false,"given":"Xiaofeng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0516-332X","authenticated-orcid":false,"given":"Chengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-9132","authenticated-orcid":false,"given":"Zhibo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5727-2782","authenticated-orcid":false,"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2023.05.031_bib2","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2023.05.031_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2215-0366(16)30030-X","article-title":"Suicide prevention strategies revisited: 10-year systematic review","volume":"3","author":"Zalsman","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.eurpsy.2011.06.003","article-title":"The European Psychiatric Association (EPA) guidance on suicide treatment and prevention","volume":"27","author":"Wasserman","year":"2012","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am\u00a0J Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/cns.12103","article-title":"Ketamine as a fast acting antidepressant: current knowledge and open questions","volume":"19","author":"Salvadore","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jaac.2023.05.031_bib8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jaac.2023.05.031_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2019.03.071","article-title":"A\u00a0preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation","volume":"251","author":"Zhan","year":"2019","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2023.05.031_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/cap.2018.0030","article-title":"Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study","volume":"28","author":"Cullen","year":"2018","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2023.05.031_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.ajp.2020.20010018","article-title":"Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial","volume":"178","author":"Dwyer","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jad.2012.08.040","article-title":"Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder\/fear of harm phenotype","volume":"147","author":"Papolos","year":"2013","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2023.05.031_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaac.2017.01.006","article-title":"Ketamine as a treatment for adolescent depression: a case report","volume":"56","author":"Dwyer","year":"2017","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib17","article-title":"Case report of subanesthetic intravenous ketamine infusion for the treatment of neuropathic pain and depression with suicidal features in a pediatric patient","volume":"2018","author":"Weber","year":"2018","journal-title":"Case Rep Anesthesiol"},{"key":"10.1016\/j.jaac.2023.05.031_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/cap.2019.0028","article-title":"Successful use of ketamine for the treatment of psychotic depression in a teenager","volume":"29","author":"Zarrinnegar","year":"2019","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jaac.2023.05.031_bib19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1186\/s12888-022-04388-y","article-title":"The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2023.05.031_bib20","doi-asserted-by":"crossref","first-page":"e719","DOI":"10.4088\/JCP.15m10056","article-title":"Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study","volume":"77","author":"Ionescu","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2023.05.031_bib21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1000","article-title":"Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures","volume":"143","author":"Cot\u00e9","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2023.05.031_bib22","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jaac.2023.05.031_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000284591","article-title":"The Brief Psychiatric Rating Scale. Dimension of schizophrenia\u2500reliability and construct validity","volume":"22","author":"Andersen","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.jaac.2023.05.031_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J\u00a0Trauma Stress"},{"key":"10.1016\/j.jaac.2023.05.031_bib26","first-page":"353","article-title":"Test-retest reliability of the Severity of Dependence Scale","volume":"92","author":"Gossop","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.jaac.2023.05.031_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addbeh.2016.03.016","article-title":"Reliability, convergent and structural validity and cut-off score of the Severity of Dependence Scale for recreational ketamine users","volume":"60","author":"Fern\u00e1ndez-Calder\u00f3n","year":"2016","journal-title":"Addict Behav"},{"key":"10.1016\/j.jaac.2023.05.031_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib29","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","volume":"376","author":"Abbar","year":"2022","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jaac.2023.05.031_bib31","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jad.2020.05.088","article-title":"The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: results from the Canadian Rapid Treatment Center of Excellence","volume":"274","author":"McIntyre","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2023.05.031_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A\u00a0systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychol Med"},{"key":"10.1016\/j.jaac.2023.05.031_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.jaac.2023.05.031_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jaac.2023.05.031_bib36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/pr.116.012484","article-title":"The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis","volume":"68","author":"Scofield","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.jaac.2023.05.031_bib37","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.4088\/JCP.16l11277","article-title":"The antidepressant effect of repeat dose intravenous ketamine is delayed by concurrent benzodiazepine use","volume":"78","author":"Albott","year":"2017","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.jaac.2023.05.031_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0000000000000316","article-title":"Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development","volume":"35","author":"Frye","year":"2015","journal-title":"J\u00a0Clin Psychopharmacol"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856723003738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856723003738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:47:32Z","timestamp":1729082852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856723003738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0890856723003738"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2023.05.031","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2023.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92023 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}